(Q40800760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Giuseppina Ortu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

Y Rozen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

R Krais

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

N M Freedman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

R Chisin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Gazit

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Levitzki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E Mishani

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

Nuclear Medicine and Biology

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

359-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

Recovery of cell subpopulations from human tumour xenografts following dissociation with different enzymes

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Sensitivity of new radiopharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Tyrphostins IV--highly potent inhibitors of EGF receptor kinase. Structure-activity relationship study of 4-anilidoquinazolines

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Application of a novel phenylpiperazine formation reaction to the radiosynthesis of a model fluorine-18-labeled radiopharmaceutical (18FTFMPP).

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal gro

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Tissue distribution of 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGF

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900200-1

7 January 2021

10.1016/S0969-8051(01)00200-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395308%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference